In Brief: Human tissue workshop
This article was originally published in The Gray Sheet
Human tissue workshop: FDA-sponsored meeting is scheduled for June 20 and 21 at the National Institutes of Health in Bethesda, Maryland, according to a May 24 Federal Register notice. The purpose of the workshop is "to provide an opportunity for continued discussion of the regulation of human tissue for transplantation as outlined by FDA in an interim rule" published in December 1993. For further information on registration, contact Julie Furman of KRA Corporation, at 301/495-1591...
You may also be interested in...
Siemens Healthineers' product mix of diagnostics and imaging products meant it was in the middle of a very dynamic situation when COVID-19 struck.
The WHO’s new "living guideline" against remdesivir’s use in hospitalized patients notwithstanding, some key opinion leaders in India see a role for the antiviral, but underscore that COVID-19 is still in its infancy and all repurposed therapies for the disease still have a long way to go. They also see the US remdesivir studies as more robust.
Join us for a brief audio tour around the past week's major global biopharma industry developments, in this podcast version of Scrip's Five Must-Know Things.